ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Grit Biotechnology clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 30 studies whose lead sponsor is Grit Biotechnology. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Grit Biotechnology with AstraZeneca and Bristol-Myers Squibb →

Pipeline: 8 programs

Each counted once: 8 with a study Grit Biotechnology leads registered in the last two years.

  • Phase 1
  • Phase 2

5 from the earlier phases, besides the phase-3 view.

Program
GT719Phase 2 · 5 live · Hematologic Neoplasms · primary completion Dec 2027☆ Track
Autologous Tumor Infiltrating Lymphocytes GT201GT201Phase 2 · 2 live · Lung Neoplasms · primary completion Apr 2027☆ Track
IB-T101 injectionPhase 1 · 1 live · Carcinoma, Renal Cell · primary completion Dec 2027☆ Track
GT801Early phase 1 · 2 live · Autoimmune Diseases · primary completion Nov 2027☆ Track
CD19-targeted iNKT Cell InjectionEarly phase 1 · 1 live · Glomerulonephritis, IGA · primary completion Jun 2028☆ Track

3 more — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Grit Biotechnology’s own registered studies; Grit Biotechnology’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Grit Biotechnology’s studies test, most open studies first — 5 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

7 of Grit Biotechnology’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. F
  5. M
  6. 2A
  7. 1M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. 2N

Add all 7 to your calendar (.ics) → With an account.

All 30 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1757%Recruiting 15 · Not yet recruiting 2
  • Under way, not recruiting27%
  • Stopped early1137%Terminated 9 · Withdrawn 2

Phase

  • Early Phase 111
  • Phase 19
  • Phase 24

Where

Over the years

  1. 21
  2. 22
  3. 23
  4. 924
  5. 25
  6. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Grit Biotechnology.

  • Grit Biotechnology
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies

Studies

Recruiting first, then most recently updated. Showing 30 of 30.